We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$712B
AUM Growth
+$31.8B
Cap. Flow
+$2.48B
Cap. Flow %
0.35%
Top 10 Hldgs %
21.18%
Holding
2,600
New
72
Increased
1,394
Reduced
949
Closed
59

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.27B
2
LLY icon
Eli Lilly
LLY
+$1.64B
3
NVDA icon
NVIDIA
NVDA
+$1.59B
4
RHT
Red Hat Inc
RHT
+$1.55B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Sector Composition

Rank Sector Weight
1 Technology 18.88%
2 Healthcare 16.96%
3 Financials 13.79%
4 Consumer Discretionary 13.57%
5 Industrials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRT
2401
DELISTED
Startek Inc.
SRT
$208K ﹤0.01%
25,507
+307
+1% +$2.35K
USAK
2402
DELISTED
USA Truck Inc
USAK
$208K ﹤0.01%
20,600
-107
-0.5% -$1.41K
PCMI
2403
DELISTED
PCM, Inc
PCMI
$206K ﹤0.01%
5,879
+179
+3% +$5.28K
AD
2404
Array Digital Infrastructure
AD
$3.04B
$205K ﹤0.01%
4,587
-1,885
-29% -$88.1K
ACU icon
2405
Acme United Corp
ACU
$228M
$203K ﹤0.01%
+9,000
New +$184K
GLRE icon
2406
Greenlight Captial
GLRE
$505M
$203K ﹤0.01%
23,903
ASXC
2407
DELISTED
Asensus Surgical, Inc.
ASXC
$202K ﹤0.01%
11,407
+72
+0.6% +$1.58K
EMCI
2408
DELISTED
EMC INS Group Inc
EMCI
$202K ﹤0.01%
+5,620
New +$193K
BFYT
2409
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$201K ﹤0.01%
7,752
AAIC
2410
DELISTED
Arlington Asset Investment Corp.
AAIC
$196K ﹤0.01%
28,512
+232
+0.8% +$1.71K
FUSB icon
2411
First US Bancshares
FUSB
$90.6M
$194K ﹤0.01%
20,950
CHRD icon
2412
Chord Energy
CHRD
$7.53B
$187K ﹤0.01%
32,970
+1,619
+5% +$9.2K
VIVO
2413
DELISTED
Meridian Bioscience Inc
VIVO
$186K ﹤0.01%
15,667
+131
+0.8% +$1.58K
AMX icon
2414
America Movil
AMX
$69.7B
$185K ﹤0.01%
12,700
VHC icon
2415
VirnetX Holding Corp
VHC
$65.8M
$185K ﹤0.01%
1,493
+6
+0.4% +$749
PLSE icon
2416
Pulse Biosciences
PLSE
$3.09B
$184K ﹤0.01%
13,975
+32
+0.2% +$437
GNE icon
2417
Genie Energy
GNE
$380M
$182K ﹤0.01%
17,113
+271
+2% +$2.52K
CHS
2418
DELISTED
Chicos FAS, Inc.
CHS
$181K ﹤0.01%
53,827
+200
+0.4% +$727
CPLG
2419
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$178K ﹤0.01%
14,340
+128
+0.9% +$1.62K
TG icon
2420
Tredegar Corp
TG
$281M
$177K ﹤0.01%
10,650
MERC icon
2421
Mercer International
MERC
$32.3M
$174K ﹤0.01%
11,220
BSET icon
2422
Bassett Furniture
BSET
$171M
$173K ﹤0.01%
11,368
+30
+0.3% +$481
ORBC
2423
DELISTED
ORBCOMM, Inc.
ORBC
$173K ﹤0.01%
23,885
+100
+0.4% +$712
DVAX
2424
DELISTED
Dynavax Technologies
DVAX
$171K ﹤0.01%
42,916
+100
+0.2% +$580
GHL
2425
DELISTED
Greenhill & Co., Inc.
GHL
$169K ﹤0.01%
12,424
+33
+0.3% +$605

Similar funds

T. Rowe Price Associates's Q2 2019 Portfolio in Review

As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
  • T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
  • T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
  • T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
  • T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
  • T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.

Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.